Veterinary Medicines

Biosuis Parvo L(6) Plus emulsion for injection for pigs

Authorised
  • Porcine parvovirus, strain Bio-37, Inactivated
  • Leptospira interrogans, serogroup Pomona, serovar Pomona, strain MSLB 1037, Inactivated
  • Leptospira borgpetersenii, serogroup Sejroe, serovar Hardjo, strain MSLB 1039, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1040, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1042, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1043, Inactivated
Download as PDF

Product identification

Medicine name:
Biosuis Parvo L(6) Plus emulsion for injection for pigs
Биосуис Парво Л(6) Плюс, инжекционна емулсия за прасета
Active substance:
  • Porcine parvovirus, strain Bio-37, Inactivated
  • Leptospira interrogans, serogroup Pomona, serovar Pomona, strain MSLB 1037, Inactivated
  • Leptospira borgpetersenii, serogroup Sejroe, serovar Hardjo, strain MSLB 1039, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1040, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1042, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1043, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain Bio-37, Inactivated
  • Leptospira interrogans, serogroup Pomona, serovar Pomona, strain MSLB 1037, Inactivated
    1.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira borgpetersenii, serogroup Sejroe, serovar Hardjo, strain MSLB 1039, Inactivated
    1.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1040, Inactivated
    1.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1042, Inactivated
    1.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
    1.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1043, Inactivated
    1.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Similar biological application (Article 13(4) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lekoom AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-3017
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 11/01/2023
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 23/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."